Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 673 to 681 of 681 entries
Sorted by: Best Match Show Resources per page
Artificial Intelligence Education Programs for Health Care Professionals: Scoping Review.

JMIR medical education

Charow R, Jeyakumar T, Younus S, Dolatabadi E, Salhia M, Al-Mouaswas D, Anderson M, Balakumar S, Clare M, Dhalla A, Gillan C, Haghzare S, Jackson E, Lalani N, Mattson J, Peteanu W, Tripp T, Waldorf J, Williams S, Tavares W, Wiljer D.
PMID: 34898458
JMIR Med Educ. 2021 Dec 13;7(4):e31043. doi: 10.2196/31043.

BACKGROUND: As the adoption of artificial intelligence (AI) in health care increases, it will become increasingly crucial to involve health care professionals (HCPs) in developing, validating, and implementing AI-enabled technologies. However, because of a lack of AI literacy, most...

Cite
Charow R, Jeyakumar T, Younus S, et al. Artificial Intelligence Education Programs for Health Care Professionals: Scoping Review. JMIR Med Educ. 2021;7(4):e31043doi: 10.2196/31043.
Charow, R., Jeyakumar, T., Younus, S., Dolatabadi, E., Salhia, M., Al-Mouaswas, D., Anderson, M., Balakumar, S., Clare, M., Dhalla, A., Gillan, C., Haghzare, S., Jackson, E., Lalani, N., Mattson, J., Peteanu, W., Tripp, T., Waldorf, J., Williams, S., Tavares, W., & Wiljer, D. (2021). Artificial Intelligence Education Programs for Health Care Professionals: Scoping Review. JMIR medical education, 7(4), e31043. https://doi.org/10.2196/31043
Charow, Rebecca, et al. "Artificial Intelligence Education Programs for Health Care Professionals: Scoping Review." JMIR medical education vol. 7,4 (2021): e31043. doi: https://doi.org/10.2196/31043
Charow R, Jeyakumar T, Younus S, Dolatabadi E, Salhia M, Al-Mouaswas D, Anderson M, Balakumar S, Clare M, Dhalla A, Gillan C, Haghzare S, Jackson E, Lalani N, Mattson J, Peteanu W, Tripp T, Waldorf J, Williams S, Tavares W, Wiljer D. Artificial Intelligence Education Programs for Health Care Professionals: Scoping Review. JMIR Med Educ. 2021 Dec 13;7(4):e31043. doi: 10.2196/31043. PMID: 34898458.
Copy Download .nbib Format: NLM
A Rare Case Report of Herbal Medication Induced Pancreatitis.

Cureus

Mowafy A, Younes I, Omran A, Elkattawy S, Yuridullah R.
PMID: 33791176
Cureus. 2021 Feb 25;13(2):e13558. doi: 10.7759/cureus.13558.

Acute pancreatitis is an acute inflammation of the pancreas that varies in clinical manifestation from mild to life-threatening that may require hospitalization. A 56-year-old male patient with a past medical history of diabetes mellitus and osteoarthritis developed acute pancreatitis...

Cite
Mowafy A, Younes I, Omran A, et al. A Rare Case Report of Herbal Medication Induced Pancreatitis. Cureus. 2021;13(2):e13558doi: 10.7759/cureus.13558.
Mowafy, A., Younes, I., Omran, A., Elkattawy, S., & Yuridullah, R. (2021). A Rare Case Report of Herbal Medication Induced Pancreatitis. Cureus, 13(2), e13558. https://doi.org/10.7759/cureus.13558
Mowafy, Ahmed, et al. "A Rare Case Report of Herbal Medication Induced Pancreatitis." Cureus vol. 13,2 (2021): e13558. doi: https://doi.org/10.7759/cureus.13558
Mowafy A, Younes I, Omran A, Elkattawy S, Yuridullah R. A Rare Case Report of Herbal Medication Induced Pancreatitis. Cureus. 2021 Feb 25;13(2):e13558. doi: 10.7759/cureus.13558. PMID: 33791176; PMCID: PMC8004472.
Copy Download .nbib Format: NLM
Risk of post-intubation cardiac arrest with the use of high-dose rocuronium in COVID-19 patients with acute respiratory distress syndrome: A retrospective cohort study.

Journal of clinical and translational research

Kandinata N, Acharya R, Patel A, Parekh A, Santana J, Darden A, Sedhai YR, Kafle S, Younus U.
PMID: 34901517
J Clin Transl Res. 2021 Oct 30;7(6):717-722. eCollection 2021 Dec 28.

BACKGROUND: Post-intubation cardiac arrest (PICA) is an uncommon complication of intubation, but numbers have risen to over 1.5 times the usual number since the coronavirus disease 2019 (COVID-19) pandemic. Due to expert recommendations, high-dose rocuronium (HDR) has become a...

Cite
Kandinata N, Acharya R, Patel A, et al. Risk of post-intubation cardiac arrest with the use of high-dose rocuronium in COVID-19 patients with acute respiratory distress syndrome: A retrospective cohort study. J Clin Transl Res. 2021;7(6):717-722
Kandinata, N., Acharya, R., Patel, A., Parekh, A., Santana, J., Darden, A., Sedhai, Y. R., Kafle, S., & Younus, U. (2021). Risk of post-intubation cardiac arrest with the use of high-dose rocuronium in COVID-19 patients with acute respiratory distress syndrome: A retrospective cohort study. Journal of clinical and translational research, 7(6), 717-722.
Kandinata, Natalie, et al. "Risk of post-intubation cardiac arrest with the use of high-dose rocuronium in COVID-19 patients with acute respiratory distress syndrome: A retrospective cohort study." Journal of clinical and translational research vol. 7,6 (2021): 717-722.
Kandinata N, Acharya R, Patel A, Parekh A, Santana J, Darden A, Sedhai YR, Kafle S, Younus U. Risk of post-intubation cardiac arrest with the use of high-dose rocuronium in COVID-19 patients with acute respiratory distress syndrome: A retrospective cohort study. J Clin Transl Res. 2021 Oct 30;7(6):717-722. eCollection 2021 Dec 28. PMID: 34901517; PMCID: PMC8654367.
Copy Download .nbib Format: NLM
Future advances and challenges of nanomaterial-based technologies for electromagnetic interference-based technologies: A review.

Environmental research

Karim SS, Murtaza Z, Farrukh S, Umer MA, Ali SS, Younas M, Mubashir M, Saqib S, Ayoub M, Bokhari A, Peter AP, Khoo KS, Ullah S, Show PL.
PMID: 34838569
Environ Res. 2021 Nov 25;205:112402. doi: 10.1016/j.envres.2021.112402. Epub 2021 Nov 25.

The emerging growth of the electronic devices applications has arisen the serious problems of electromagnetic (EM) wave pollution which resulting in equipment malfunction. Therefore, polymer-based composites have been considered good candidates for better EMI shielding due to their significant...

Cite
Karim SS, Murtaza Z, Farrukh S, et al. Future advances and challenges of nanomaterial-based technologies for electromagnetic interference-based technologies: A review. Environ Res. 2021;205:112402doi: 10.1016/j.envres.2021.112402.
Karim, S. S., Murtaza, Z., Farrukh, S., Umer, M. A., Ali, S. S., Younas, M., Mubashir, M., Saqib, S., Ayoub, M., Bokhari, A., Peter, A. P., Khoo, K. S., Ullah, S., & Show, P. L. (2021). Future advances and challenges of nanomaterial-based technologies for electromagnetic interference-based technologies: A review. Environmental research, 205112402. https://doi.org/10.1016/j.envres.2021.112402
Karim, Syed Shujaat, et al. "Future advances and challenges of nanomaterial-based technologies for electromagnetic interference-based technologies: A review." Environmental research vol. 205 (2021): 112402. doi: https://doi.org/10.1016/j.envres.2021.112402
Karim SS, Murtaza Z, Farrukh S, Umer MA, Ali SS, Younas M, Mubashir M, Saqib S, Ayoub M, Bokhari A, Peter AP, Khoo KS, Ullah S, Show PL. Future advances and challenges of nanomaterial-based technologies for electromagnetic interference-based technologies: A review. Environ Res. 2021 Nov 25;205:112402. doi: 10.1016/j.envres.2021.112402. Epub 2021 Nov 25. PMID: 34838569.
Copy Download .nbib Format: NLM
Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes.

Circulation

Filippatos G, Anker SD, Agarwal R, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Schloemer P, Tornus I, Joseph A, Bakris GL.
PMID: 33198491
Circulation. 2021 Feb 09;143(6):540-552. doi: 10.1161/CIRCULATIONAHA.120.051898. Epub 2020 Nov 16.

BACKGROUND: The FIDELIO-DKD trial (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease) evaluated the effect of the nonsteroidal, selective mineralocorticoid receptor antagonist finerenone on kidney and cardiovascular outcomes in patients with chronic kidney disease and...

Cite
Filippatos G, Anker SD, Agarwal R, et al. Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes. Circulation. 2020;143(6):540-552doi: 10.1161/CIRCULATIONAHA.120.051898.
Filippatos, G., Anker, S. D., Agarwal, R., Pitt, B., Ruilope, L. M., Rossing, P., Kolkhof, P., Schloemer, P., Tornus, I., Joseph, A., Bakris, G. L. (2021). Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes. Circulation, 143(6), 540-552. https://doi.org/10.1161/CIRCULATIONAHA.120.051898
Filippatos, Gerasimos, et al. "Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes." Circulation vol. 143,6 (2021): 540-552. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.051898
Filippatos G, Anker SD, Agarwal R, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Schloemer P, Tornus I, Joseph A, Bakris GL. Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes. Circulation. 2021 Feb 09;143(6):540-552. doi: 10.1161/CIRCULATIONAHA.120.051898. Epub 2020 Nov 16. PMID: 33198491; PMCID: PMC7864612.
Copy Download .nbib Format: NLM
Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDA.

Journal of clinical pharmacology

Pai SM, Othman AA, Rusch L, Masters JC, Greene D, Rogge M, Gries JM, Clementi W, Kumar P, Younis I, Salem AH, Gaynes BI, Pastino G, Derendorf H.
PMID: 33274473
J Clin Pharmacol. 2021 Mar;61(3):277-279. doi: 10.1002/jcph.1794. Epub 2021 Jan 27.

No abstract available.

Cite
Pai SM, Othman AA, Rusch L, et al. Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDA. J Clin Pharmacol. 2021;61(3):277-279doi: 10.1002/jcph.1794.
Pai, S. M., Othman, A. A., Rusch, L., Masters, J. C., Greene, D., Rogge, M., Gries, J. M., Clementi, W., Kumar, P., Younis, I., Salem, A. H., Gaynes, B. I., Pastino, G., Derendorf, H. (2021). Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDA. Journal of clinical pharmacology, 61(3), 277-279. https://doi.org/10.1002/jcph.1794
Pai, Sudhakar M, et al. "Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDA." Journal of clinical pharmacology vol. 61,3 (2021): 277-279. doi: https://doi.org/10.1002/jcph.1794
Pai SM, Othman AA, Rusch L, Masters JC, Greene D, Rogge M, Gries JM, Clementi W, Kumar P, Younis I, Salem AH, Gaynes BI, Pastino G, Derendorf H. Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDA. J Clin Pharmacol. 2021 Mar;61(3):277-279. doi: 10.1002/jcph.1794. Epub 2021 Jan 27. PMID: 33274473; PMCID: PMC7754558.
Copy Download .nbib Format: NLM
The Neuroprotective Efficacy of Postnatal Magnesium Sulfate in Term or Near-Term Infants With Moderate-to-Severe Birth Asphyxia.

Cureus

Iqbal N, Younus J, Malik M, Fatima B, Imran A, Maqbool S, Irfan Waheed KA, Haque K.
PMID: 34513419
Cureus. 2021 Aug 02;13(8):e16826. doi: 10.7759/cureus.16826. eCollection 2021 Aug.

Background In Pakistan, the neonatal mortality rate is 41 per 1,000 live births and birth asphyxia is one of the leading causes of neonatal mortality and morbidity. The goal of this study was to determine whether postnatal magnesium sulfate...

Cite
Iqbal N, Younus J, Malik M, et al. The Neuroprotective Efficacy of Postnatal Magnesium Sulfate in Term or Near-Term Infants With Moderate-to-Severe Birth Asphyxia. Cureus. 2021;13(8):e16826doi: 10.7759/cureus.16826.
Iqbal, N., Younus, J., Malik, M., Fatima, B., Imran, A., Maqbool, S., Irfan Waheed, K. A., & Haque, K. (2021). The Neuroprotective Efficacy of Postnatal Magnesium Sulfate in Term or Near-Term Infants With Moderate-to-Severe Birth Asphyxia. Cureus, 13(8), e16826. https://doi.org/10.7759/cureus.16826
Iqbal, Nadeem, et al. "The Neuroprotective Efficacy of Postnatal Magnesium Sulfate in Term or Near-Term Infants With Moderate-to-Severe Birth Asphyxia." Cureus vol. 13,8 (2021): e16826. doi: https://doi.org/10.7759/cureus.16826
Iqbal N, Younus J, Malik M, Fatima B, Imran A, Maqbool S, Irfan Waheed KA, Haque K. The Neuroprotective Efficacy of Postnatal Magnesium Sulfate in Term or Near-Term Infants With Moderate-to-Severe Birth Asphyxia. Cureus. 2021 Aug 02;13(8):e16826. doi: 10.7759/cureus.16826. eCollection 2021 Aug. PMID: 34513419; PMCID: PMC8407416.
Copy Download .nbib Format: NLM
Artificial intelligence for photonics and photonic materials.

Reports on progress in physics. Physical Society (Great Britain)

Piccinotti D, MacDonald KF, A Gregory S, Youngs I, Zheludev NI.
PMID: 33355315
Rep Prog Phys. 2021 Jan;84(1):012401. doi: 10.1088/1361-6633/abb4c7.

Artificial intelligence (AI) is the most important new methodology in scientific research since the adoption of quantum mechanics and it is providing exciting results in numerous fields of science and technology. In this review we summarize research and discuss...

Cite
Piccinotti D, MacDonald KF, A Gregory S, et al. Artificial intelligence for photonics and photonic materials. Rep Prog Phys. 2021;84(1):012401doi: 10.1088/1361-6633/abb4c7.
Piccinotti, D., MacDonald, K. F., A Gregory, S., Youngs, I., & Zheludev, N. I. (2021). Artificial intelligence for photonics and photonic materials. Reports on progress in physics. Physical Society (Great Britain), 84(1), 012401. https://doi.org/10.1088/1361-6633/abb4c7
Piccinotti, Davide, et al. "Artificial intelligence for photonics and photonic materials." Reports on progress in physics. Physical Society (Great Britain) vol. 84,1 (2021): 012401. doi: https://doi.org/10.1088/1361-6633/abb4c7
Piccinotti D, MacDonald KF, A Gregory S, Youngs I, Zheludev NI. Artificial intelligence for photonics and photonic materials. Rep Prog Phys. 2021 Jan;84(1):012401. doi: 10.1088/1361-6633/abb4c7. PMID: 33355315.
Copy Download .nbib Format: NLM
Future advances and challenges of nanomaterial-based technologies for electromagnetic interference-based technologies: A review.

Environmental research

Karim SS, Murtaza Z, Farrukh S, Umer MA, Ali SS, Younas M, Mubashir M, Saqib S, Ayoub M, Bokhari A, Peter AP, Khoo KS, Ullah S, Show PL.
PMID: 34838569
Environ Res. 2021 Nov 25;205:112402. doi: 10.1016/j.envres.2021.112402. Epub 2021 Nov 25.

The emerging growth of the electronic devices applications has arisen the serious problems of electromagnetic (EM) wave pollution which resulting in equipment malfunction. Therefore, polymer-based composites have been considered good candidates for better EMI shielding due to their significant...

Cite
Karim SS, Murtaza Z, Farrukh S, et al. Future advances and challenges of nanomaterial-based technologies for electromagnetic interference-based technologies: A review. Environ Res. 2021;205:112402doi: 10.1016/j.envres.2021.112402.
Karim, S. S., Murtaza, Z., Farrukh, S., Umer, M. A., Ali, S. S., Younas, M., Mubashir, M., Saqib, S., Ayoub, M., Bokhari, A., Peter, A. P., Khoo, K. S., Ullah, S., & Show, P. L. (2021). Future advances and challenges of nanomaterial-based technologies for electromagnetic interference-based technologies: A review. Environmental research, 205112402. https://doi.org/10.1016/j.envres.2021.112402
Karim, Syed Shujaat, et al. "Future advances and challenges of nanomaterial-based technologies for electromagnetic interference-based technologies: A review." Environmental research vol. 205 (2021): 112402. doi: https://doi.org/10.1016/j.envres.2021.112402
Karim SS, Murtaza Z, Farrukh S, Umer MA, Ali SS, Younas M, Mubashir M, Saqib S, Ayoub M, Bokhari A, Peter AP, Khoo KS, Ullah S, Show PL. Future advances and challenges of nanomaterial-based technologies for electromagnetic interference-based technologies: A review. Environ Res. 2021 Nov 25;205:112402. doi: 10.1016/j.envres.2021.112402. Epub 2021 Nov 25. PMID: 34838569.
Copy Download .nbib Format: NLM
Showing 673 to 681 of 681 entries